English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/100106
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Prognostic biomarkers for survival after treatment of a cancer disease with radio-therapy and/or chemotherapy

AuthorsCarnero, Amancio
Issue Date12-Sep-2013
CitationWO2013132001 A1
AbstractThe present invention new methods of using proteins markers MAP17 and/or SGLT1, or mRNA encoding these proteins, as indicators for survival after treatment of a human subject suffering from a cancer disease with radiotherapy and/or chemotherapy.
Appears in Collections:(IBIS) Patentes
Files in This Item:
File Description SizeFormat 
WO2013132001A1.pdf6,69 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.